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Abstract
Recent evidence suggests that :90% of retinal ganglion cells (RGCs) die by the process of apoptosis within 14 days of optic
nerve transection. RGCs begin to disappear from the retina between 5 and 7 days postaxotomy when the highest percentage of
RGCs show characteristics typical of apoptosis. A single intraocular injection of glial cell-line derived neurotrophic factor
(GDNF) given at the time of axotomy resulted in a delay in the initiation of RGC death and increased the densities of surviving
RGCs at 7, 10 and 14 days postaxotomy. The mean RGC densities in GDNF treated retinas at 7 (23819144), 10 (15619117)
and 14 (11239116) days postaxotomy were significantly higher than that of controls (1835982, 8359272 and 485939,
respectively). The loss of RGCs was paralleled by increases in TUNEL positive staining in control retinas and a lower percentage
of TUNEL positive cells in GDNF treated retinas at 5, 7 and 10 days postaxotomy. These results suggest that GDNF is capable
of promoting RGC survival following injury, possibly by interfering with an essential step in apoptosis. © 1998 Elsevier Science
Ltd. All rights reserved.
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1. Introduction
The innermost neuronal layer of the retina is com-
prised of the retinal ganglion cells (RGCs) which pro-
ject their axons into the optic nerve. Retinal ganglion
cells are well suited to the study of neuronal degenera-
tion and regeneration because the optic nerve is easily
accessible within the orbit and all of the RGCs can be
completely axotomized in a reproducible manner. Ap-
plication of retrograde tracers to the cut end of the
optic nerve labels RGCs within hours, permitting the
time course of RGC death to be studied for many
weeks postaxotomy. Finally, the cell bodies of RGCs
are located in close proximity to the vitreous chamber
of the eye, facilitating the delivery of trophic molecules
by direct intraocular injections.
Transection of the optic nerve in adult rats results in
the death of more than 90% of RGCs within a 2 week
period [1–3]. Following transection of the optic nerve,
the number of RGCs remains nearly constant for ap-
proximately 5 days and then decreases. With more
distal lesions of the optic nerve the pattern of RGC
death differs. When lesions are made intracranially, the
period before RGC death onset increases to approxi-
mately 7 days and fewer RGCs are lost [4]. During the
period between optic nerve transection and the onset of
RGC death, neurons show little change in essential
physiological processes. The rates of slow axonal trans-
port along RGC axons and the expression of mRNA
for proteins such as tubulin and neurofilament subunits
remains normal [5]. However, 7 days following transec-
tion, slow axonal transport rates fall several-fold and
the levels of mRNA for tubulin and neurofilament
subunits decrease by aproximately 50% [5]. These
changes are indicative of the ordered alterations in
cellular functions that precede RGC death following
axotomy. One of the proposed mechanisms for RGC
death following axotomy is the loss of trophic support
from targets [6]. Target derived trophic factors may be
necessary for the maintenance of RGC populations
within the eye.
Recent evidence has implicated the process of apop-
tosis, in RGC degeneration following axotomy. DNA
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nicking and fragmentation, which characterizes pro-
grammed cell death, has been detected using terminal
transferase end-labeling [7]. Retinal ganglion cells have
been shown to exhibit such DNA fragmentation follow-
ing axotomy [4,8]. The density of apoptotic cells in-
creases between 5 and 7 days following optic nerve
transection and then decreases [8], similar to the ob-
served decline in RGC numbers.
Apoptosis is believed to occur through a cascade of
events involving the activation of specific proteases
which cleave intracellular proteins and ultimately leads
to the destabilization and destruction of the DNA
within the cell. The proteases implicated in apoptosis
belong to the family of cysteine proteases that share
structural homology with interleukin-1b-converting en-
zyme (ICE) [9]. The ICE family of proteases are struc-
turally related to the products of the ced-3 gene in C.
elegans. The ced-3 protein is required for all develop-
mentally related programmed cell deaths in C. elegans
[10]. CPP32, is a member of the ICE proteases that is
most closely related to Ced-3. CPP32 is also referred to
as apopain and distinguished by its ability to cleave
poly(ADP-ribose) polymerase (PARP) during pro-
grammed cell death [11]. PARP is capable of ADP-ri-
bosylating nuclear acceptor proteins, topoisomerases
and histones, altering their functions [12]. PARP cleav-
age by ICE proteases during programmed cell death
leads to diminished DNA repair capabilities and the
active phase of programmed cell death, including DNA
fragmentation. The involvement of ICE proteases in
programmed cell death is further supported by evidence
that ICE protease inhibitors prevent the naturally oc-
curring cell death of specific types of neurons including
developing motorneurons [13].
A variety of approaches have been taken to enhance
RGC survival following optic nerve transection. The
viability of RGCs, which have had their axons tran-
sected, can be increased by grafting a segment of pe-
ripheral nerve to the optic nerve stump at the time of
transection [14,1]. Glia within the grafted segment of
peripheral nerve may act as a source of trophic factors
that promote RGC survival or may act to induce the
production of trophic factors by surrounding cells.
Although peripheral nerve graft transplantation ap-
pears promising, only 5% of RGCs ever regenerate their
axons into the graft [1]. This may be due to the fact
that many of the RGCs are dying and others are unable
to regenerate their axons through the degenerating op-
tic nerve stump. Another proposed method for prevent-
ing the cascade of events related to apoptosis is to
provide exogenous inductive survival signals. Neuro-
trophic factors may provide these rescue signals to cells
which have been axotomized or injured. Injections of
brain derived neurotrophic factor (BDNF) into the eye
have been shown to enhance the survival of RGCs
[15,3] and promote the regrowth of axons from RGCs
[16]. Equivalent enhancements in RGC survival have
been observed after single intraocular injections of neu-
rotrophin-4:5 [3]. With prolonged administration, NT-
4:5 has also been shown to promote axonal sprouting
and regrowth [16]. The majority of RGCs have also
been shown to express trkB, a high affinity receptor for
both BDNF and NT-4:5 [17].
Glial cell-line derived neurotrophic factor (GDNF) is
a member of the TGF-b superfamily [18]. It has re-
cently been shown to be a growth and survival factor
for neuronal cells. GDNF promotes the survival of
various populations of peripheral sensory and sympa-
thetic neurons, as well as motorneurons [19]. GDNF
has also been shown to promote the survival of mid-
brain dopaminergic neurons [18]. Recently, GDNF
mRNA has been found to be expressed during develop-
ment in many sensory and motor areas of the nervous
system, including the retina [20]. The GDNF receptor
consists of Ret [19], a tyrosine kinase receptor and
GDNFR-a, an extracellular protein anchored in the
membrane by glycosylphosphatidyl inositol (GPI) [21].
GDNF has been shown to induce the phosphorylation
of Ret only in the presence of GDNFR-a. The current
model for receptor activation involves a heterotetramer
of two GDNF and two GDNFR-a molecules activating
the Ret tyrosine kinase [21]. In the present study we
examined the effects of GDNF on RGC survival and
apoptosis following optic nerve transection.
2. Methods
2.1. Animals
Adult, female Sprague–Dawley rats (250–300 g;
Charles River) that were free of common pathogens
were used in all experiments. Animals were kept in a
level B, pathogen controlled environment and housed
in standard cages with micron air filters for pathogen
control. Animals were cared for according to the Cana-
dian Council on Animal Care. Rats were anesthetized
with intraperitoneal injections of 7% Chloral Hydrate
(420 mg:kg of body weight) during experimental proce-
dures. A local topical anaesthetic (2% xylocaine) was
applied to the cornea and an ophthalmic eye ointment
(Lacri-Lube, Allergan, Markham, ON), was applied to
prevent corneal dessication. Animals were covered dur-
ing surgery and their temperatures were monitored in
order to avoid hypothermia. Following surgery, rats
were placed in a recovery cage on top of a heating
blanket set at 40°C and given an intraperitoneal injec-
tion of Temgesic (1:10 dilution), to minimize postsurgi-
cal discomfort.
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2.2. Intraorbital axotomy and retrograde labeling
The optic nerve was accessed within the orbit by
making an incision in the skin covering the superior
rim of the orbital bone. The superior orbital contents
were dissected and the rectus muscles were reflected
laterally. In order to expose the optic nerve and sur-
rounding dura mater sheath, the eye was rotated in a
temporal direction by retracting the transected seg-
ments of extraocular muscle. Following rotation of
the eye, the dural sheath surrounding the optic nerve
was cut longitudinally to avoid cutting blood vessels
while revealing the optic nerve. The exposed optic
nerve was completely transected within 2 mm of the
eye. RGCs were retrogradely labeled at the time of
optic nerve transection by applying Dextran-FITC to
the cut end of the optic nerve. Five microlitres of a
10% solution of Dextran-FITC dissolved in 0.9% ster-
ile sodium chloride was injected into the proximal end
of the optic nerve stump using a Hamilton microsy-
ringe. The integrity of the retinal vasculature was
evaluated by a postoperative ophthalmoscopy. Rats
with compromised vasculature were not included in
the experimental results.
2.3. Intraocular GDNF administration
One eye of experimental animals served as a control
while the other received GDNF treatment. The retinas
of the experimental group (GDNF treatment follow-
ing axotomy) were used to determine the effects of
GDNF on RGC survival up to 14 days following
optic nerve transection (Day 1, n4; Day 3, n4;
Day 5, n5; Day 7, n6; Day 10, n6; Day 14,
n7). Immediately following optic nerve transection,
5 ml of GDNF (Calbiochem; LaJolla, CA; 1 mg:5 ml
PBS) was injected into the vitreous chamber of the
eye by a posterior route. A 30 gauge needle was used
to puncture the sclera, within 4 mm of the optic nerve
origin. GDNF was administered using a 5 ml SGE
microliter syringe (Type A-RN, Austin, TX). Care
was taken not to damage the lens, which could lead
to cataract formation, or anterior structures of the
eye, which could be a source of endogenous growth
factors [15]. Control injections of 5 ml PBS were made
at the same time in the contralateral eye. Following
intraocular injections, the needle was withdrawn
slowly and the puncture in the sclera was sealed using
Histoacryl Blue tissue cement (Davis and Geck, Mon-
treal, PQ).
2.4. Tissue processing
Rats were killed by an overdose of anesthetic and
their eyes enucleated. The cornea and lens were dis-
sected away and the remaining eye cups were fixed for
3 h in a solution consisting of 4% paraformaldehyde
and 2% sucrose, in Sorensen’s phosphate buffer (0.1
M, pH 7.3). Following fixation, eyes were rinsed in a
Rinse buffer (0.1 M sodium phosphate buffer, 15%
sucrose, 0.2 mM CaCl2, pH 6.9) for 30 min and
placed in a 30% sucrose solution in Rinse buffer over
night. Excess vitreous was blotted away with paper
wicks and the eyecups were bisected into two hemi-
spheres. The retina of one hemisphere was flat-
mounted and coverslipped in Vectashield mounting
medium (Vector Laboratories, Burlingame, CA). The
retina of the other hemisphere was sectioned using a
cryostat microtome. Eyecups were embedded in OCT
compound (Tissue-Tek, Miles, Elkhart, IN) and sec-
tioned at 21°C. Sections were 12 mm thick and
collected on APTEX-coated slides (Sigma, St. Louis,
MO.).
2.5. TUNEL assay
Apoptotic nuclei in Dextran-FITC retrogradely la-
beled RGCs were identified using bromo-deoxyuridine
triphosphate (Br-dUTP) end-labeling [8], on retinal
sections. Biotinylated Br-dUTP was used in all assays.
Prior to the TUNEL reaction, sections were rinsed in
PBS (pH 7.3) for 10 min to remove OCT embedding
compound. Sections were incubated for 2 h at 37°C
in a reaction solution containing: 50 ml reaction buffer
(1 M potassium cacodylate, 125 mM Tris–HCl,
bovine serum albumin, 1.25 mg:ml), 1 ml terminal
transferase, 5 ml 25 mM CoCl2, 1.5 ml Br-dUTP
(Boehringer Mannheim, Laval, PQ). Sections were
rinsed in PBS (pH 7.3) for an additional 10 min,
incubated in Streptavidin-Texas Red (1:500 dilution in
Rinse buffer) for 2 h, rinsed in PBS (pH 7.3) for 10
min and coverslipped in glycerol.
2.6. Fluorescence 6isualization and retinal ganglion cell
counts
Retrogradely labeled RGCs in flatmounts were vi-
sualized using a Zeiss laser scanning confocal micro-
scope (LSM-10). An argon laser (wavelength 488 nm)
was used for the visualization of FITC fluorescence
and a helium-neon laser (wavelength 543 nm) was
used for the visualization of Texas Red. Labeled
RGCs were counted from composite confocal micro-
graphs covering an area of 78000 mm2. Each com-
posite micrograph consisted of overlays of ten
sequential confocal sections, taken at different depths
within the retinal ganglion cell layer. This technique
ensured that every cell in the RGC layer was repre-
sented in micrographs, despite irregularities in the to-
pography of the flatmount. Confocal micrographs of
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Fig. 1. Graph showing the mean densities of Dextran-FITC labeled retinal ganglion cells for GDNF treated (solid line) and control (hatched line)
retinas (RGC s:mm29S.D.). Mean RGC densities were calculated at 1, 3, 5, 7, 10 and 14 days postaxotomy. GDNF treated retinas demonstrated
higher mean cell densities than that of control retinas at 5, 7, 10 and 14 days postaxotomy. The delay in RGC death onset was prolonged from
5 to 7 days postaxotomy in GDNF treated retinas compared to control retinas.
five randomly selected areas from each flatmounted
retina were counted. All areas selected for micrographs
were taken at a radial distance of approximately 2 mm
from the optic disc. The results for separate retinas
were pooled for statistical analysis and the mean RGC
densities:mm2 were calculated. Statistically significant
differences between control and GDNF treated retinas,
at different timepoints, were detected using Fisher’s
PLSD (protected least squares difference) and Scheffe’s
F-test. These post-hoc group comparisons were made
following analysis of variance at PB0.005. Apoptotic
nuclei labeled with the TUNEL assay were visualized
by epifluorescence microscopy. A 490 nm wavelength
filter pack (Reichert) was used to localize Dextran-
FITC labeled RGCs and a 546 nm wavelength filter
pack (Reichert) was used for the visualization of apop-
totic nuclei stained with Texas Red. The number of
apoptotic nuclei and RGCs were counted along the
complete length of each retinal section. Apoptotic nu-
clei were counted only if they were present within
Dextran-FITC labeled cells. This insured that only
apoptotic RGCs were enumerated. Approximately 300
to 600 cells per slide were counted. At each time period
(5, 7, 10, 14 days postaxotomy), 3 slides containing
sections processed with the TUNEL assay were counted
for each rat. The results were expressed as a percentage
of TUNEL positive Dextran-FITC RGCs at each time
point examined.
3. Results
3.1. Effects of axotomy on control retinal ganglion cell
densities
Dextran-FITC fluorescence could be localized in the
somata and primary dendrites of RGCs as early as 1
day postaxotomy. At this time, FITC fluorescence was
intense and diffusely localized throughout the cyto-
plasm of RGCs. At 10 and 14 days postaxotomy, FITC
fluorescence was as intense, however, the pattern of
fluorescence in RGC somata was more punctate and
concentrated in small vesicular structures. Between 1
and 3 days postaxotomy there was no significant RGC
death (Fig. 1). The retinal ganglion cell densities at 1
and 3 days were 24069127 (mean9S.D.) and 24349
104, respectively. At 5 days postaxotomy, the mean
RGC density in control retinas decreased slightly
(21929192), however this did not represent a signifi-
cant change in RGC numbers. In control retinas, Dex-
tran-FITC labeled cells that did not demonstrate
normal RGC morphology were visible after 5 days
postaxotomy. These cells, which have a small, ramified
appearance, have been previously observed and pro-
posed to be microglia [22]. Transcellularly labeled mi-
croglia had fine linear processes which appeared to be
directed towards the optic disc. There were greater
reductions in RGC densities in retinas examined after 7
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and 10 days postaxotomy. At 7 days postaxotomy (Fig.
2a,b), the mean control RGC density (1835982), was
reduced to 76% of its original value. By 10 days postax-
otomy, the mean RGC density (8359272) had de-
creased to 35% of the original population density.
Transcellularly labeled microglia became most promi-
nent between 7 and 10 days postaxotomy. The decrease
in the mean RGC density to 485939 at 14 days
postaxotomy represents a diminution in RGC densities
to 20% of the intact population. At 14 days postaxo-
tomy, control retinas exhibited low numbers of viable
RGCs interspersed between transcellularly labeled mi-
croglia (Fig. 3a,b). These results demonstrate that RGC
densities remain unchanged for approximately 5 days
postaxotomy and then gradually decrease, resulting in a
loss of 80% of the original RGC population.
Fig. 3. Confocal micrographs of Dextran-FITC labeled RGCS in
control retinal flatmounts at 14 days postaxotomy. Fewer RGC
somata were seen interspersed between labeled microglia and linear
microglial processes than at 7 days postaxotomy. The processes of
microglia were oriented towards the optic disc. At low magnification:
(a) high numbers of microglia and degenerating RGCs were visible,
between the large somata of viable RGCs. At high magnification. (b),
the large somata of RGCs (large arrows) were clearly distinguishable
from the smaller microglial cells (small arrows) and degenerating
RGCs.
Fig. 2. Confocal micrographs of Dextran-FITC labeled RGCs in
control flatmounts, 7 days following axotomy. Micrographs depict
representative regions taken at different magnifications. (a) A low
magnification micrograph shows numerous fine linear processes of
transcellularly labeled microglia located between RGC somata. (b) At
a higher magnification, the small cell bodies of labeled microglia and
microglial processes (small arrows) and RGCs (large arrows) were
visible.
3.2. Effects of intraocular GDNF administration
GDNF treated retinas exhibited similar RGC densi-
ties to control retinas at 1, 3 and 5 days postaxotomy
(Fig. 1). The mean RGC densities (9S.D.) at 1, 3 and
5 days were 24309100, 24409108 and 23419146,
respectively. Transcellularly labeled microglia were not
apparent in GDNF treated retinas at the 5 day postax-
otomy period. RGC population densities were main-
tained at their original levels until 7 days postaxotomy.
The 7 day RGC density (23819144) was significantly
higher than that of 7 day control retinas. Despite
exhibiting a greater degree of structural integrity and
higher RGC densities, labeled microglia became visible
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in GDNF treated retinas 7 days following optic nerve
transection (Fig. 4a,b). After 10 and 14 days postaxo-
tomy, RGC densities in GDNF treated retinas had
decreased significantly to 15619117 and 11239116,
respectively. These represent RGC survival rates of
64% and 46% at 10 and 14 days postaxotomy. After 14
days following axotomy, GDNF treated retinas (Fig.
5a,b) displayed higher numbers of viable RGCs com-
pared to controls. Transcellular microglial labeling at
14 days was also lower than that of comparable con-
trols. These results demonstrate that GDNF increases
the latency period for the onset of RGC death from 5
days postaxotomy to approximately 7 days postaxo-
tomy. Furthermore, the mean density of RGCs at 14
Fig. 5. Confocal micrographs of RGCs retrogradely labeled with
Dextran-FITC in GDNF treated retinal flatmounts at 14 days
postaxotomy. Micrographs show representative regions at similar
distances from the optic disc. At 14 days following optic nerve
transection, GDNF treated retinas exhibited higher densities of viable
RGCs and lower densities of transcellularly labeled microglia than
control retinas (Fig. 3a,b). At low magnification (a), few labeled
microglia were visible and at high magnification (b), the small somata
of microglia (small arrows) could be seen interspersed between higher
numbers of viable RGCs (large arrows).
Fig. 4. Confocal micrographs of Dextran-FITC labeled RGCs in
GDNF treated retinas at 7 days postaxotomy. GDNF treated retinas
demonstrated higher RGC densities and lower numbers of labeled
microglia than comparable control retinas (Fig. 2a,b) at 7 days
postaxotomy. Micrographs of flatmounts were taken of similar repre-
sentative regions at low and high magnifications. At low magnifica-
tion; (a) GDNF treated retinas displayed a higher degree of structural
integrity than controls, with less microglial labeling. At high magnifi-
cation: (b), the large somata of intact RGCs (large arrows) and
smaller labeled microglia (small arrows) were distinguishable.
days postaxotomy in GDNF treated retinas represented
a loss of only 64% of the original Dextran-FITC la-
beled RGC population. GDNF administration signifi-
cantly enhanced RGC survival following optic nerve
transection and more than doubled the density of Dex-
tran-FITC labeled RGCs after 14 days postaxotomy,
compared to control retinas.
3.3. TUNEL labeling of apoptotic retinal ganglion cells
TUNEL labeling of fragmented nuclear DNA in
RGCs was intense and specific. Texas Red fluorescence
was uniform throughout the nuclear region of labeled
RGCs. Colocalization of TUNEL labeling and Dex-
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tran-FITC labeling was confirmed in confocal micro-
scope overlays of double labeled RGCs (Fig. 6). The
nuclei of TUNEL stained cells appeared to be displaced
within the cytoplasm of retrogradely labeled RGCs.
The percentage of TUNEL positive nuclei (mean9
S.D.) in control retinas increased between 5 days
(2.1%90.36%) and 7 days (4.6%90.50%) postaxo-
tomy (Fig. 7). Beyond 7 days postaxotomy, the percent-
age of TUNEL positive RGCs in control retinas
decreased to 3.1% (90.20%) at 10 days postaxotomy.
A larger decrement in the percentage of TUNEL posi-
tive nuclei was seen between 10 and 14 days postaxo-
tomy. The percentage of TUNEL positive RGCs at 14
days postaxotomy dropped to 1.2% (90.40%). The
percentage of TUNEL positive nuclei in GDNF treated
retinas was lower at all time points tested with the
exception of 14 days postaxotomy. The percentage of
TUNEL positive nuclei in GDNF treated retinas in-
creased from 0.3% (90.17%) at 5 days postaxotomy to
1.1% (90.56%) at 7 days postaxotomy (Fig. 7). At the
7 day period, the percentage of TUNEL positive RGCs
in GDNF treated retinas was one quarter of the value
for control retinas. Confocal images of TUNEL stained
retinal sections demonstrate lower numbers of TUNEL
stained RGCs per length of retina in GDNF treated
eyes than in control eyes (Fig. 8). At 10 days following
optic nerve transection, the percentage of TUNEL pos-
itive RGC nuclei in the GDNF treatment group
reached a maximum of 2.2% (9 0.43%). This value
dropped to 0.9% (90.25%) at 14 days postaxotomy.
Overall, these results indicate that the percentage of
TUNEL positive nuclei in control retinas begins to
increase at 5 days postaxotomy, while the percentage of
TUNEL stained nuclei in GDNF treated retinas begins
to increase at 7 days postaxotomy. The percentage of
TUNEL positive nuclei in both control and GDNF
treated retinas reached a maximum approximately 2–3
days after the initial increases in TUNEL positive RGC
percentages. Following this period, the number of
TUNEL positive nuclei in both control and GDNF
treated retinas decreased to approximately 1.0% at 14
days postaxotomy. GDNF administration significantly
reduced the percentage of apoptotic nuclei at 5, 7 and
10 days postaxotomy and prolonged the delay in apop-
totic RGC death by approximately 2 days beyond that
of control injections.
4. Discussion
The results of these experiments suggest that GDNF
is capable of promoting RGC survival following optic
nerve transection. Single injections of GDNF main-
tained the structural integrity of the retinal ganglion
cell layer for approximately 7 days postaxotomy. The
inability of GDNF to promote ganglion cell survival
beyond this period may be due to a number of factors
requiring further study. GDNF present in the vitreous
humor may have been degraded by free extracellular
proteases released as a consequence of RGC degenera-
tion. Extracellular GDNF may also have been endocy-
tosed by microglia and degraded intracellularly. Thanos
and Thiel [23] have demonstrated the importance of
microglial protease activity in partially determining the
outcome of RGC degeneration following axotomy. The
delivery of protease inhibitors to the vitreous chamber
has been shown to inhibit endocytosis-dependent label-
ing of microglia [23]. Similar inhibition of microglial
phagocytic activity might increase the effective period
of GDNF availability to RGCs, thereby promoting
survival beyond 7 days postaxotomy. The effects of
GDNF may also be limited by the stability of the
polypeptide chain following injection into the vitreous
Fig. 6. Confocal micrographs demonstrating colocalization of Dex-
tran-FITC retrograde labeling (a) and TUNEL staining with Texas
Red (b) in the same retinal ganglion cell, from a vertical section of
control retina. The TUNEL stained nucleus (Fig. 6b; large arrow)
was displaced within the soma of the apoptotic retinal ganglion cell
(Fig. 6a; large arrow). Ilm, inner limiting membrane.
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Fig. 7. Graph showing the mean percentages of TUNEL stained nuclei (9 SD) in 12 mm thick vertical retinal sections. The percentages of
TUNEL positive RGC nuclei were examined at 5, 7, 10 and 14 days postaxotomy in GDNF treated and control retinas. GDNF treated retinas
exhibited lower percentages of TUNEL stained nuclei at 5, 7 and 10 days postaxotomy. At 14 days postaxotomy, GDNF and control retinas
displayed similar percentages of TUNEL positive RGC nuclei.
chamber. After 5–7 days post-injection, the environment
within the vitreous chamber could denature the GDNF
homodimers, resulting in diminished RGC survival ef-
fects beyond this period of time.
Single intraocular injections of GDNF produced en-
hancements in RGC survival that were comparable to
single intraocular BDNF injections [15,3]. Interestingly,
prolonged administration of BDNF has been shown to
be no more effective than single injections in enhancing
RGC survival for more than 7 days postaxotomy [15].
Mansour–Robaey and colleagues (1994) have attributed
this observation to differential expression of truncated
trkB receptors following continued BDNF signal trans-
duction through the full length receptor gp145trkB.
Multiple truncated forms and the full length form of trkB
arise through differential mRNA splicing in vivo. Trun-
cated trkB isoforms have been shown to have inhibitory
effects on BDNF signaling in the central nervous system.
These trkB isoforms could assert such negative regula-
tory effects by binding BDNF and forming non-func-
tional heterodimers with full length trkB receptors [24].
Biffo et al. [25] have also demonstrated that truncated
trkB receptors are capable of retarding BDNF diffusion
by binding BDNF with high affinity, leading to rapid
internalization of the ligand-receptor complex.
As in the case with BDNF, multiple injections or
prolonged administration of GDNF may be no more
effective than single injections in promoting RGC sur-
vival following axotomy. Our preliminary observations
suggest that this is the case. With the recent characteri-
zation of the GDNF receptor has come the discovery of
alternate truncated forms of Ret, the tyrosine kinase
receptor involved in GDNF signal transduction. These
could exert a negative role in regulating GDNF-based
RGC survival, similar to that of truncated trkB isoforms
in the case of prolonged BDNF administration. Indeed,
multiple isoforms of the Ret tyrosine kinase mRNA have
been recently characterized by Lorenzo et al. [26]. These
forms include alternate mRNA isoforms predicted to
encode membrane spanning receptors with truncated
extracellular ligand-binding domains. Another soluble
receptor isoform has also been reported based on the
characterization of mRNA transcripts [26]. Myers et al.
[27] have sequenced the full length Ret coding region and
characterized the transcripts generated by alternative
splicing. Their results have led them to speculate that up
to 40 different full length Ret transcripts may exist.
Although not yet reported, it is possible that multiple
forms of Ret with truncated intracellular domains exist,
similar to that of the truncated trkB receptors. Truncated
Ret receptors could form non-functional heterodimers
with full length receptors, thereby competing for avail-
able extracellular GDNF. The upregulation of these
non-functional truncated forms could account for the
diminished effects of GDNF beyond 7 days postaxo-
tomy.
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Although prolonged administration of GDNF, like
BDNF, might not enhance RGC survival beyond 7
days, treatments that do not trigger the expression of
truncated receptor forms may be more effective in
enhancing RGC survival postaxotomy. If the upregula-
tion of truncated receptor forms is dependent on the
intensity of signaling through the full-length Ret ty-
rosine kinase, a single intraocular injection of an opti-
mal dose of GDNF may enhance RGC survival
without promoting the expression of truncated forms.
The current model for Ret activation involves the
binding of GDNF to its recently characterized receptor,
GDNFR-a, forming a heterotetramer that promotes
Ret dimerization [21]. Upon dimerization the tyrosine
kinase activity of Ret ultimately activates the mitogen
activated protein kinase (MAPK) signal transduction
pathway [28]. The MAP kinase pathway is similarly
activated by signaling through the trk neurotrophin
receptors [29], trkB [30] and trkC [31]. Cells lacking the
GDNFR-a receptor are also capable of responding to
GDNF because the receptor may be soluble [21]. It is
therefore possible that the enhancement of RGC sur-
vival that we observed after a single injection of GDNF
could be due to effects of the neurotrophic factor on
cells other than RGCs. GDNF may bind the GDNFR-
a receptor on glial cells or other neuronal cells in close
proximity to the ganglion cell layer. This receptor-lig-
and complex may then diffuse away, binding to Ret or
another homologous receptor expressed on the RGCs.
Alternatively, Lorenzo et al. [26] have predicted the
possible expression of soluble Ret receptors. Soluble
forms of the Ret receptor may be expressed on either
glial cells or neurons, possibly leading to effects on the
RGCs by a soluble GDNF-GDNFR-a-Ret complex.
This tripartite complex could diffuse throughout the
extracellular environment and dimerize Ret on the
RGC somata or bind another receptor, inducing signal
transduction. GDNF has previously been shown to
provide trophic support for dopaminergic midbrain
neurons [18], sensory and motor neurons [19] and
GDNF mRNA is expressed during development in
many different cellular systems, including retina [20]. It
is therefore possible that GDNF might exert its trophic
effects through several retinal cell types, including neu-
rons other than RGCs and glial cells.
The TUNEL assay has been widely used to identify
apoptotic nuclei in cells undergoing programmed cell
death. However, this technique detects in situ DNA
fragmentation and should not be considered to be a
specific marker for apoptosis [32,33]. Various types of
cell death, including apoptosis, necrosis and autolytic
cell death, may involve DNA fragmentation. However,
the reported cases of non-specific TUNEL labeling are
highly dependent on the conditions of cell death and
the specific factors inducing cell death. Moreover, the
results of several studies suggest that the death of the
majority of retinal ganglion cells following axotomy
occurs by the processes of apoptosis [4,8]. The finding
that the percentage of TUNEL positive RGC nuclei
labeled over time can be altered by administration of
GDNF and that this correlates well with the time
course of observed cell death, provides additional sup-
port for the contention that a population of RGCs may
die by the process of apoptosis following axotomy.
The disappearance of RGCs from the ganglion cell
layer following axotomy closely follows the increase in
RGCs that have fragmented DNA. Retinal ganglion
cell death in control retinas first becomes apparent at 5
days postaxotomy. This corresponds to an increase in
the percentage of apoptotic nuclei between 5 and 7 days
postaxotomy. The increase in the percentage of apop-
totic nuclei in GDNF treated retinas at 7 days postaxo-
tomy also corresponds to the decrease in RGC densities
Fig. 8. Confocal micrographs of TUNEL stained RGC nuclei (large
arrows) at 7 days postaxotomy in 12 mm thick vertical sections from
control (a) and GDNF (b) treated retinas. GDNF treated retinas
displayed lower numbers of apoptotic nuclei compared to control
retinas at 7 days postaxotomy. TUNEL staining was visualized with
Texas Red. Ilm, inner limiting membrane; ipl, inner plexiform layer.
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between 7 and 10 days following axotomy. Interest-
ingly, the percentages of apoptotic nuclei at 14 days
postaxotomy in control and GDNF-treated retinas do
not differ significantly. The drop in the percentage of
apoptotic nuclei at 14 days postaxotomy indicates that
the population of RGCs surviving at this period of time
may remain relatively unchanged beyond 14 days.
While GDNF was not effective in preventing RGC
death past 7 days postaxotomy, there were significant
increases in RGC survival at 10 and 14 days postaxo-
tomy, compared to controls. At 14 days postaxotomy,
the RGC population densities in GDNF treated retinas
were more than double that of control RGC densities.
The increased RGC survival at 14 days postaxotomy, in
addition to the diminished rate of apoptosis, may be
due to GDNF exerting protective effects on a select
population of RGCs, as opposed to a non-responsive
population of RGCs which did not survive axotomy
past 7 days. It is possible that the population of RGCs
that did not survive past 7 days was minimally respon-
sive to GDNF or only transiently responsive to GDNF.
Delayed programmed cell death or apoptosis is there-
fore a likely explanation for the observed preservation
of the retinal ganglion cell layer for 7 days postaxo-
tomy, followed by a predictable decrease in the RGC
population after GDNF treatment.
5. Conclusions
Our results suggest that GDNF promotes the sur-
vival of retinal ganglion cells following axotomy, more
than doubling the density of surviving RGCs after 14
days postaxotomy. GDNF administration delays the
onset of RGC death from 5 to 7 days postaxotomy. It
appears however, that the postaxotomy protective ef-
fects of GDNF are limited to a specific population of
RGCs that are responsive to GDNF administration.
The increase in the survival of RGCs in GDNF treated
retinas correlates well with the percentages of apoptotic
nuclei at the time periods tested. GDNF treated retinas
exhibit decreased percentages of apoptotic nuclei at 5, 7
and 10 days postaxotomy compared to control retinas.
Following an initial increase in the percentage of apop-
totic nuclei, there is a marked decrease in positive
TUNEL labeling of RGCs in both GDNF and control
retinas. The relatively low percentages of apoptotic
nuclei observed in GDNF and control retinas at 14
days postaxotomy indicates that a significant propor-
tion of cells surviving axotomy to 14 days may remain
viable beyond this period of time.
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